Purpose Breast cancer-related lymphedema (BCRL) represents a lifelong risk for breast
cancer survivors and once acquired becomes a lifelong burden. This review summarizes …

The number of cancer survivors continues to increase in the United States due to the growth
and aging of the population as well as advances in early detection and treatment. To assist …

Background Lymphedema affects one in six breast cancer survivors making it a global
healthcare challenge. There is considerable debate about the efficacy of different treatments …

Background Early diagnosis and compression treatment are important to prevent
progression in breast cancer-related arm lymphedema (BCRAL). However, some mild …

As the prognosis of early breast cancer (BC) continues to improve, patients and physicians
are increasingly focused on post-treatment quality of life (QOL). Despite great efforts to de …

PURPOSE The PREVENT randomized trial assessed progression to chronic breast cancer–
related lymphedema (cBCRL) after intervention triggered by bioimpedance spectroscopy …

Immediate lymphatic reconstruction (ILR) at the time of axillary lymph node dissection
(ALND) has become increasingly utilized for the prevention of breast cancer related …

Objective To establish a consensus regarding the multidisciplinary prevention of breast
cancer‐related lymphedema (BCRL), taking into account the expert opinion of professional …

Purpose Breast cancer–related lymphedema (BCRL) represents a dreaded complication of
breast cancer treatment that can lead to morbidity, diminished quality of life, and …

Historically, axillary lymph node dissection (ALND) was regarded as part of the curative
management of breast cancer. However, after clinical trials made it clear that ALND did not …